
OPUS GENETICS INC
IRD · NASDAQ
Updated at 2026-10-15 04:54:16
- Today's High
- $4.39
- Today’s Low
- $4.08
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.39
- Previous Close
- $4.10
- Volume
- 1.19M
- Market Cap
- $386.02M
- P/E Ratio
- --
- EPS
- $-1.29
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 8 DAVIS DRIVE, DURHAM, NC, UNITED STATES, 27713
- Country
- US
- Listing Date
- 2004-11-30
- Fiscal Year End
- December
- Shares Outstanding
- 82.57M
- CIK
- 0001228627
- Website
- opusgtx.com
Opus Genetics, Inc. (IRD) is a pioneering biotechnology company dedicated to advancing gene therapies for rare retinal diseases that affect vision. Utilizing cutting-edge gene-editing techniques and a strong research framework, Opus Genetics seeks to address significant unmet medical needs in ocular health. The company's innovative pipeline, bolstered by ongoing clinical trials and strategic partnerships, positions it favorably within the dynamic healthcare sector, offering substantial growth potential for institutional investors.
Financial Metrics
Revenue
2026-06-30
$755K
2026-03-31
$2.15M
2025-12-31
$3.86M
2025-09-30
$3.07M
Operating Expenses
2026-06-30
$17.23M
2026-03-31
$16.5M
2025-12-31
$15.31M
2025-09-30
$11.39M
Net Income
2026-06-30
-$8.09M
2026-03-31
-$65.53M
2025-12-31
-$16.52M
2025-09-30
-$17.45M
Net Profit Margin
2026-06-30
-1.07K%
2026-03-31
-3.03K%
2025-12-31
-427.5%
2025-09-30
-566.87%
Earnings Per Share
2026-06-30
$-0.14
2026-03-31
$-0.75
2025-12-31
$-0.21
2025-09-30
$-0.25
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$7.55M
2026-03-31
-$64.87M
2025-12-31
-$15.11M
2025-09-30
-$17.37M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $755K | $2.15M | $3.86M | $3.07M |
| Operating Expenses | $17.23M | $16.5M | $15.31M | $11.39M |
| Net Income | -$8.09M | -$65.53M | -$16.52M | -$17.45M |
| Net Profit Margin | -1.07K% | -3.03K% | -427.5% | -566.87% |
| Earnings Per Share | $-0.14 | $-0.75 | $-0.21 | $-0.25 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$7.55M | -$64.87M | -$15.11M | -$17.37M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.